GlucoLight Corporation Raises Second Tranche of ''c'' Round Financing
BETHLEHEM, Pa.--(BUSINESS WIRE)--GlucoLight Corporation, a development-stage company focused on non-invasive, continuous blood glucose monitoring, today announced the closing of the second
Read Full Article
Related Articles
- Bioptigen Completes Series A Round Funding Investment Closes at $1.3 Million also categorized in Funding
- Report identifies $200M OCT market also categorized in Funding
- OCTANe Foundation for Innovation Grants $20,000 Innovation Award also published in businesswire.com
- GlucoLight Corporation Raises Second Tranche of “c” Round Financing also categorized in Funding
- Imalux Awarded $2.3 Million Research Grant also categorized in Funding
- Successful OCT imaging during cancer surgery also categorized in Funding
- OCT market to top $800 million by 2012 also categorized in Funding
- GlucoLight Corporation Raises Third Tranche Of ''c'' Round Financing also categorized in Funding
- Method and apparatus for monitoring glucose levels in a biological tissue also mentions GlucoLight
- GlucoLight Unveils Ergonomic Improvements and Performance Enhancements ... also mentions Ray Krauss
Login to comment.